![](/img/cover-not-exists.png)
771 Paclitaxel and carboplatin as adjuvant treatment in high-risk patients with operable non-small cell lung cancer (NSCLC): A feasibility study conducted by the hellenic cooperative oncology group (HeCOG)
H. Timotheadou, Ch. Christodoulou, Ch. Papakonstantinou, S. Papadopoulos, J. Skrickova, E. Samantas, P. Papakostas, G. FountzilasVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90796-8
File:
PDF, 169 KB
english, 2003